Castle Biosciences financial statements

캐슬 바이오사이언시스NASDAQ:CSTL · Nasdaq · Healthcare · sector #16
$33.36-8.98%
2026-10-06 close · prelim

Castle Biosciences's published financial data is dated 2026-10-04. 2024 revenue was $332M. 2024 operating profit was $9M.

Reported results

Castle Biosciences notifications

Quantus Signal · live data · not investment advice · Privacy Policy
Q